Novapio Plus 15 mg/850 mg filmom obložene tablete
| Name | Novapio Plus 15 mg/850 mg filmom obložene tablete |
|---|---|
| Former Name | Pioglitazon/metformin Novatin 15 mg/850 mg filmom obložene tablete |
| Marketing Authorisation Number | HR-H-412849202 |
| Active Substance | pioglitazonklorid metforminklorid |
| Composition | jedna tableta sadrži 15 mg pioglitazona (u obliku klorida) i 850 mg metforminklorida |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Atlantic Pharma – Produções Farmacêuticas, S.A., Sintra, Portugal |
| Marketing Authorisation Holder | Novatin Limited, 230, Second Floor, Eucharistic Congress Road, Mosta, Malta |
| Marketing Authorisation Date | 18.05.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/22-02/163 |
| Registration Number | 381-12-01/154-23-07 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | A10BD05 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
